Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Flyer for OBN's BioTuesday 23.03.2021

The event will feature a welcome from Kath Mackay (Managing Director at Alderley Park), a keynote from MiNA Therapeutics, and a series of showcase presentations from companies who are using RNA in their product development.

Messenger RNA molecules carry the genetic information needed to make proteins and trigger an immune response, while RNA interference can modify gene expression. Researchers have been studying and working with RNA molecules for decades. However, on the example of the mRNA vaccines, the pandemic has accelerated this transformative technology and following unprecedented industry collaborations, we have now seen the world’s first mRNA vaccine being rolled out to the wider population - this session will look at the future potential for this exciting technology.

Click here for more information

Click here to register